Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,431 | -21,744 | -12,874 | -1,700 | -10,238 |
| Depreciation Amortization | 580 | 2,595 | 7,058 | 1,574 | 1,076 |
| Accounts receivable | -112 | -607 | 4,129 | 622 | 358 |
| Other Working Capital | 1,532 | 1,545 | 2,976 | 2,980 | 639 |
| Other Operating Activity | 20,107 | 13,368 | -3,247 | -10,777 | -246 |
| Operating Cash Flow | $-9,324 | $-4,843 | $-1,958 | $-7,301 | $-8,411 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 759 | N/A | -3,070 | 361 | 1,374 |
| PPE Investments | -18 | -5 | -3 | 307 | -221 |
| Net Acquisitions | -305 | N/A | 550 | 8,365 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 684 | -666 |
| Investing Cash Flow | $436 | $-5 | $-2,523 | $9,717 | $487 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 400 | N/A | 5,432 | 2,633 | N/A |
| Debt Repayment | -639 | -1,327 | -106 | -7,055 | -310 |
| Common Stock Issued | 15 | 35 | N/A | N/A | N/A |
| Other Financing Activity | 2,444 | 8,672 | 0 | 577 | 9,299 |
| Financing Cash Flow | $2,220 | $7,380 | $5,326 | $-3,845 | $8,989 |
| Exchange Rate Effect | N/A | N/A | N/A | 3 | -17 |
| Beginning Cash Position | 9,345 | 4,389 | 349 | 1,775 | 727 |
| End Cash Position | 2,677 | 6,921 | 1,194 | 349 | 1,775 |
| Net Cash Flow | $-6,668 | $2,532 | $845 | $-1,426 | $1,048 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,324 | -4,843 | -1,958 | -7,301 | -8,411 |
| Capital Expenditure | -31 | -18 | -3 | -28 | -221 |
| Free Cash Flow | -9,355 | -4,861 | -1,961 | -7,329 | -8,632 |